Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/03/19
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 01/31/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 04/01/12
End: 12/31/24
Due: 12/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy | NCT04076449 | yuanli Zhao | user2@example.com | None | 2019-09-03 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events | NCT04205578 | yuanli Zhao | user2@example.com | None | 2020-01-31 | 2022-12-31 | 2023-12-31 | - | - | 2025-07-14 |
| Pediatric and Adult Cerebral Arteriovenous Malformation Neurofunctional Outcomes | NCT04593966 | yuanli Zhao | user2@example.com | None | 2012-04-01 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |